DYNEY JOSEPH: Open Payments
NPI 1720331440 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$947 in 30 payments from 20 companies in 2025. Trend: 2023 $1,451 · 2024 $926 · 2025 $947
Food & beverage: $848Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $163 |
| E.R. Squibb & Sons, L.L.C. | 1 | $116 |
| Astellas Pharma US Inc | 3 | $94 |
| Alexion Pharmaceuticals, Inc. | 2 | $64 |
| ABBVIE INC. | 3 | $61 |
| Legend Biotech USA Inc. | 1 | $53 |
| SANOFI-AVENTIS U.S. LLC | 1 | $43 |
| Karyopharm Therapeutics Inc. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Stemline Therapeutics Inc. | 1 | $31 |
Products named: BREYANZI, ULTOMIRIS, Xospata, CARVYKTI, REZUROCK, XPOVIO, MONJUVI, EPKINLY.
Industry payments across TX — which companies pay providers there.
